Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer’s disease

[1]  W. Heiss,et al.  New diagnostic criteria for multiple sclerosis , 2002, Annals of neurology.

[2]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[3]  V. Gerbaud,et al.  Mechanism of Calcite Crystal Growth Inhibition by the N-terminal Undecapeptide of Lithostathine* , 2000, The Journal of Biological Chemistry.

[4]  S. Veesler,et al.  Biophysical Characterization of Lithostathine , 1999, The Journal of Biological Chemistry.

[5]  J. Claverie,et al.  Crystallization and preliminary crystallographic study of HIP/PAP, a human C-lectin overexpressed in primary liver cancers. , 1999, Acta crystallographica. Section D, Biological crystallography.

[6]  R. Veerhuis,et al.  The importance of inflammatory mechanisms for the development of Alzheimer’s disease , 1999, Experimental Gerontology.

[7]  J. Overmier,et al.  Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli , 1999, Neuroscience & Biobehavioral Reviews.

[8]  C. Cahill,et al.  Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences* , 1999, The Journal of Biological Chemistry.

[9]  R. Majocha,et al.  Indomethacin Reverses the Microglial Response to Amyloid β-Protein , 1998, Neurobiology of Aging.

[10]  A. M. Szczepanik,et al.  Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. , 1998, Brain research. Molecular brain research.

[11]  H. Ghanbari,et al.  Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. , 1997, The Journal of clinical investigation.

[12]  V. Singh,et al.  Circulating cytokines in Alzheimer's disease. , 1997, Journal of psychiatric research.

[13]  J. Hardy,et al.  The presenilins and Alzheimer's disease. , 1997, Human molecular genetics.

[14]  P. Aisen.  Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. , 1997, Gerontology.

[15]  J. Dagorn,et al.  Pancreatic Lithostathine as a Calcite Habit Modifier* , 1996, The Journal of Biological Chemistry.

[16]  N. Brown,et al.  Profiles of neuronal thread protein expression in Alzheimer's disease. , 1996, Journal of neuropathology and experimental neurology.

[17]  Brian J Cummings,et al.  β-Amyloid converts an acute phase injury response to chronic injury responses , 1996, Neurobiology of Aging.

[18]  J. Dagorn,et al.  Induction of lithostathine/reg mRNA expression by serum from rats with acute pancreatitis and cytokines in pancreatic acinar AR-42J cells. , 1996, Archives of biochemistry and biophysics.

[19]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[20]  D. Munoz,et al.  Role of microglia in senile plaque formation , 1995, Neurobiology of Aging.

[21]  K. Blennow,et al.  Cerebrospinal fluid 'neuronal thread protein' comes from serum by passage over the blood-brain barrier. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[22]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[23]  D. Choi.  Alzheimer's disease research , 1994, Neurobiology of Aging.

[24]  D. Walker,et al.  Pathological proteins in senile plaques. , 1994, The Tohoku journal of experimental medicine.

[25]  J. Grendell.  The pancreas, biology, pathobiology, and disease. 2nd ed , 1994 .

[26]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. McDonald,et al.  Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.

[28]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[29]  J. Wands,et al.  Characterization of thread proteins expressed in neuroectodermal tumors. , 1993, Cancer research.

[30]  A. Kaszniak,et al.  Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.

[31]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[32]  J. Dagorn,et al.  Human pancreatitis-associated protein. Messenger RNA cloning and expression in pancreatic diseases. , 1992, The Journal of clinical investigation.

[33]  G. Forloni,et al.  Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. , 1992, Brain research. Molecular brain research.

[34]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[35]  P. Mecocci,et al.  Blood‐brain‐barrier in a geriatric population: barrier function in degenerative and vascular dementias , 1991, Acta neurologica Scandinavica.

[36]  J. Dagorn,et al.  Pancreatic gene expression is altered during acute experimental pancreatitis in the rat. , 1991, The American journal of physiology.

[37]  L. Buée,et al.  Elevated circulating tumor necrosis factor levels in Alzheimer's disease , 1991, Neuroscience Letters.

[38]  W. Fiers,et al.  Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? , 1991, Immunology today.

[39]  J. Dagorn,et al.  Rat pancreatic stone protein messenger RNA. Abundant expression in mature exocrine cells, regulation by food content, and sequence identity with the endocrine reg transcript. , 1991, The Journal of biological chemistry.

[40]  B. Yankner,et al.  Nerve growth factor potentiates the neurotoxicity of beta amyloid. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Wands,et al.  Enhanced expression of an exocrine pancreatic protein in Alzheimer's disease and the developing human brain. , 1990 .

[42]  I Karlsson,et al.  Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors , 1990, Acta neurologica Scandinavica.

[43]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[45]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[47]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[48]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[49]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[50]  S. Ohman,et al.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.

[51]  B. Delpech,et al.  Étude quantitative des immunoglobulines G et de l'albumine du liquide cephalo rachidien , 1972 .

[52]  C. Adams.  Alzheimer's disease research: a game of connect the dots. , 1997, Gerontology.

[53]  J. Scuvée-Moreau,et al.  Towards a pharmacological approach of Alzheimer's disease based on the molecular biology of the amyloid precursor protein (APP). , 1994, Life sciences.

[54]  J. Gross,et al.  Elevated levels of an exocrine pancreatic secretory protein in Alzheimer disease brain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.